Figure 1
Kaplan–Meier curves for PFS by ASCT status in the ASPIRE trial: (a) prior ASCT, (b) 1R1T, and (c) no prior ASCT. Vertical dashed line indicates the time point after which carfilzomib was discontinued according to study protocol.
Figure 1 | Leukemia
